PubRank

C Salvarani

Author PubWeight™ 102.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2008 4.88
2 EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008 3.37
3 Retrocalcaneal bursitis in spondyloarthropathy: assessment by ultrasonography and magnetic resonance imaging. J Rheumatol 1998 2.68
4 EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2008 2.25
5 Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis 1999 1.97
6 Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum 2005 1.94
7 Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 2004 1.76
8 Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis. Br J Rheumatol 1993 1.52
9 Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) 2008 1.52
10 Dactylitis also involving the synovial sheaths in the palm of the hand: two more cases studied by magnetic resonance imaging. Ann Rheum Dis 1998 1.44
11 Polymyalgia rheumatica: a disorder of extraarticular synovial structures? J Rheumatol 1999 1.44
12 Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997 1.33
13 Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis 2008 1.32
14 RS3PE syndrome: an overview. Clin Exp Rheumatol 2000 1.32
15 The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 2000 1.30
16 Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum 2001 1.27
17 Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. Clin Exp Rheumatol 2000 1.24
18 Behçet's disease and cardiovascular involvement. Lupus 2005 1.23
19 Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol 2005 1.16
20 Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 2000 1.15
21 Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis 2002 1.13
22 Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 2000 1.13
23 The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) 2008 1.12
24 Classification of inflammatory arthritis. Lancet 1998 1.07
25 Vascular endothelial growth factor production in polymyalgia rheumatica. Arthritis Rheum 2000 1.06
26 Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study. Rheumatology (Oxford) 2007 1.06
27 Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 2001 1.04
28 Remitting distal extremity swelling with pitting edema: a distinct syndrome or a clinical feature of different inflammatory rheumatic diseases? J Rheumatol 1997 1.02
29 Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol 1999 0.98
30 Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol 2006 0.98
31 Relationship between plasma profiles of oxytocin and adrenocorticotropic hormone during suckling or breast stimulation in women. Horm Res 1991 0.97
32 Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset. Curr Opin Rheumatol 2001 0.96
33 The causes of uveitis in a referral centre of Northern Italy. Int Ophthalmol 2010 0.94
34 Muscoloskeletal manifestations in inflammatory bowel disease. Can J Gastroenterol 2001 0.91
35 Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum 1996 0.91
36 Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs. Rheumatology (Oxford) 2008 0.91
37 More on remitting seronegative symmetrical synovitis with pitting edema as paraneoplastic syndrome. J Rheumatol 1998 0.90
38 Remitting distal lower extremity swelling with pitting oedema in acute sarcoidosis. Ann Rheum Dis 1997 0.90
39 Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 2005 0.89
40 Rheumatoid arthritis or psoriatic symmetric polyarthritis? A difficult differential diagnosis. Clin Exp Rheumatol 2002 0.89
41 Distal extremity swelling with pitting edema in polymyalgia rheumatica: a case studied with MRI. Clin Exp Rheumatol 1998 0.89
42 18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective. Exp Gerontol 2003 0.88
43 Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheumatol 2008 0.87
44 Diagnostic approach in a patient presenting with polymyalgia. Clin Exp Rheumatol 1999 0.87
45 Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate. Arthritis Rheum 2001 0.87
46 Erythrocyte sedimentation rate and C-reactive protein in the diagnosis of polymyalgia rheumatica. Ann Intern Med 1998 0.87
47 Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapy. Ann N Y Acad Sci 2002 0.86
48 [Chronic periaortitis]. Internist (Berl) 2010 0.86
49 Is Behçet's disease part of the spondyloarthritis complex? J Rheumatol 1997 0.85
50 Intercellular adhesion molecule-1 gene polymorphisms in Behçet's Disease. J Rheumatol 2001 0.85
51 CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy. Br J Rheumatol 1996 0.84
52 Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 2004 0.84
53 Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway. Rheumatology (Oxford) 2007 0.83
54 Long-term outcome of giant cell arteritis. Clin Exp Rheumatol 2006 0.82
55 Psoriatic disease: concepts and implications. J Eur Acad Dermatol Venereol 2010 0.82
56 Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's disease. Clin Exp Rheumatol 2009 0.81
57 Serum levels of long pentraxin PTX3 in patients with polymyalgia rheumatica. Clin Exp Rheumatol 2010 0.81
58 Polymyalgia rheumatica and giant cell arteritis. Baillieres Clin Rheumatol 1995 0.81
59 Interleukin-1 cluster and tumor necrosis factor-alpha gene polymorphisms in polymyalgia rheumatica. Clin Exp Rheumatol 2001 0.80
60 Synovial expression of vasoactive intestinal peptide in polymyalgia rheumatica. Clin Exp Rheumatol 2006 0.80
61 Do we need 18F-FDG-positron emission tomography as a functional imaging technique for diagnosing large vessel arteritis? Clin Exp Rheumatol 2004 0.80
62 Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp Rheumatol 2001 0.80
63 Pulse steroid treatment of polymyalgia rheumatica. Clin Exp Rheumatol 2004 0.80
64 Elevated soluble intercellular adhesion molecule 1 in the serum of patients with polymyalgia rheumatica: influence of steroid treatment. J Rheumatol 1994 0.80
65 Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol 2014 0.80
66 Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. Clin Exp Rheumatol 2001 0.80
67 Isolated tenosynovitis associated with psoriasis triggered by physical injury. Clin Exp Rheumatol 1999 0.79
68 Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature. Rheumatology (Oxford) 2008 0.79
69 Epidemiology of psoriatic arthritis. Reumatismo 2012 0.79
70 Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment. Clin Exp Rheumatol 1994 0.78
71 Incidence of stroke in young adults in the Reggio Emilia area, northern Italy. Neuroepidemiology 1993 0.78
72 The codon 72 polymorphic variants of p53 in Italian rheumatoid arthritis patients. Clin Exp Rheumatol 2007 0.78
73 Primary Sjogren's syndrome associated with chronic periaortitis. Rheumatology (Oxford) 2007 0.78
74 Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs. Reumatismo 2014 0.78
75 Diagnostic and classification criteria, clinical and functional assessment, and therapeutic advances for spondyloarthropathies. Curr Opin Rheumatol 1997 0.78
76 Cutaneous vasculitis and cancer: a clinical approach. Clin Exp Rheumatol 2000 0.78
77 Distal extremity swelling with pitting edema in psoriatic arthritis: a case-control study. Clin Exp Rheumatol 2001 0.78
78 The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. Clin Exp Rheumatol 2010 0.78
79 Synovitis in polymyalgia rheumatica: an immunogenetic study. Br J Rheumatol 1992 0.78
80 Behçet's disease with unusual cutaneous lesions. J Rheumatol 1998 0.78
81 Immunohistochemical analysis of an additional case of focal myositis. Clin Exp Rheumatol 1996 0.77
82 Circulating RANKL/OPG in polymyalgia rheumatica. Clin Exp Rheumatol 2007 0.77
83 Involvement of transitional lumbosacral joints in spondyloarthritis. Clin Exp Rheumatol 1999 0.77
84 Elevated serum concentrations of the chemokine RANTES in patients with polymyalgia rheumatica. Clin Exp Rheumatol 1998 0.77
85 Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol 2009 0.77
86 Late-onset rheumatoid arthritis and late-onset spondyloarthritis. Clin Exp Rheumatol 2009 0.77
87 1T magnetic resonance imaging in the diagnosis of giant cell arteritis: comparison with ultrasonography and physical examination of temporal arteries. Clin Exp Rheumatol 2008 0.77
88 Lack of association of the -463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients. Rheumatology (Oxford) 2007 0.77
89 Therapy with cyclosporine in psoriatic arthritis. Semin Arthritis Rheum 1997 0.77
90 Pulmonary artery involvement in Takayasu arteritis. PET/CT versus CT angiography. Clin Exp Rheumatol 2013 0.76
91 The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A. Rheumatol Int 1998 0.76
92 Erythema nodosum: a clinical approach. Clin Exp Rheumatol 2001 0.76
93 Treatment of thrombophlebitis of Behçet's disease with low dose cyclosporin A. Clin Exp Rheumatol 1999 0.76
94 Italian evidence-based recommendations for the management of ankylosing spondylitis: the 3E Initiative in Rheumatology. Clin Exp Rheumatol 2009 0.76
95 Possible association between eosinophilic fasciitis and subcutaneous heparin use. J Rheumatol 1998 0.76
96 Pre-pregnancy counselling of patients with vasculitis. Rheumatology (Oxford) 2008 0.76
97 Protein Z G79A and A-13G gene polymorphisms in Italian patients with Behçet's disease. Clin Exp Rheumatol 2009 0.76
98 Immunologic effects in patients with psoriatic arthritis treated with cyclosporine A. J Rheumatol 1992 0.76
99 A case of arthritis and vasculitis associated with the refractory anemia with excess of blasts syndrome resistant to glucocorticoid treatment that responded favorably to TNF-alpha blockade. Clin Exp Rheumatol 2006 0.76
100 Shoulder sonographic findings in polymyalgia rheumatica. J Rheumatol 1999 0.75
101 Lack of association between chronic hepatitis C virus infection and Behçet's disease. Clin Exp Rheumatol 1997 0.75
102 Is 18F-FDG PET a 'potentially hazardous' or an effective tool in evaluating patients with large-vessel vasculitis? Clin Exp Rheumatol 2013 0.75
103 Polymyalgia rheumatica. Lancet 1996 0.75
104 Anticardiolipin antibodies in northern Italian population with PMR/GCA. Am J Med 1992 0.75
105 Upper limb lymphedema in inflammatory arthropathy. J Rheumatol 1995 0.75
106 Polymyalgia rheumatica and seronegative rheumatoid arthritis: some considerations based on a northern Italian population. J Rheumatol 1993 0.75
107 Upper limb lymphedema in psoriatic arthritis. J Rheumatol 1990 0.75
108 [Acute myelosclerosis. Evolution in acute lymphoblastic leukemia]. Haematologica 1984 0.75
109 [Left atrial thrombosis in patients with antiphospholipid antibody syndrome and mesenchymal abnormal septum]. Ital Heart J Suppl 2001 0.75
110 High dose immunoglobulin therapy in a case of inclusion body myositis: clinical and immunologic aspects. J Rheumatol 1993 0.75
111 [Disease activity assessment in large vessel vasculitis]. Reumatismo 2011 0.75
112 An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease. J Eur Acad Dermatol Venereol 2009 0.75
113 The value of CD8 assessment in distinguishing polymyalgia rheumatica from early elderly onset rheumatoid arthritis [corrected]. J Rheumatol 1996 0.75
114 [Reactive arthritis: advances in diagnosis and treatment]. Reumatismo 2002 0.75
115 [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society]. Reumatismo 2004 0.75
116 Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA). Reumatismo 2016 0.75
117 Cranial giant cell arteritis evolving into early large-vessel vasculitis. Clin Exp Rheumatol 2008 0.75
118 Tocilizumab in glucocorticoid-naïve large-vessel vasculitis. Clin Exp Rheumatol 2013 0.75
119 [The Reynolds syndrome. Clinical case and review of the literature. Analogy with graft-versus-host disease]. G Clin Med 1981 0.75
120 Magnetic resonance imaging in the diagnosis of PMR. Clin Exp Rheumatol 2000 0.75
121 Large vessel vasculitis. Clin Exp Rheumatol 2004 0.75
122 Clinical and pathologic study on eleven cases of systemic vasculitis. Contrib Nephrol 1991 0.75
123 Autoimmune disease in hairy-cell leukemia: systemic vasculitis and anticardiolipin syndrome. Clin Exp Rheumatol 1989 0.75
124 Established and new treatments of the idiopathic inflammatory myopathies: dermatomyositis and polymyositis. Clin Exp Rheumatol 2008 0.75
125 Extra-articular rheumatoid arthritis imaged by [18F]FDG-PET/CT. Acta Reumatol Port 2016 0.75
126 Retrocalcaneal bursitis in polymyalgia rheumatica. Ann Rheum Dis 2001 0.75
127 Serum chemokines in patients with psoriatic arthritis treated with cyclosporin A. J Rheumatol 1998 0.75
128 Hip bursitis in active polymyalgia rheumatica: report of a case. Clin Exp Rheumatol 1999 0.75
129 Sjögren's syndrome in human immunodeficiency virus (HIV) infection: association with HLA-DR3 and CD8 lymphocytosis in an Italian patient. Clin Exp Rheumatol 1991 0.75
130 Giant-cell arteritis of the female genital tract associated with occult temporal arteritis and FDG-PET evidence of large-vessel vasculitis. Clin Exp Rheumatol 2007 0.75
131 Polyarteritis nodosa and HIV infection: no evidence of a direct pathogenic role of HIV. Infection 1996 0.75
132 Thalidomide, deep venous thrombosis and vasculitis. J Thromb Haemost 2004 0.75
133 Reelin levels are increased in synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2010 0.75
134 Cutaneous vasculitis: a diagnostic approach. Clin Exp Rheumatol 2004 0.75
135 Gold induced severe aplastic anemia: medullary autologous reconstitution after immunosuppression. J Rheumatol 1985 0.75
136 Synovitis in polymyalgia rheumatica: a 5-year followup study in Reggio Emilia, Italy. J Rheumatol 1987 0.75
137 First international conference on polymyalgia rheumatica and giant cell arteritis, Prato, Italy. May 25-26, 1999. J Rheumatol 2000 0.75
138 Synovial expression of cell adhesion molecules in polymyalgia rheumatica. Clin Exp Immunol 1997 0.75
139 [Malignant myelofibrosis. Evolution toward acute lymphoblastic leukemia]. Nouv Presse Med 1982 0.75
140 Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis involving the central nervous system: case report and review of the literature. Clin Exp Rheumatol 2010 0.75
141 Nephrotic syndrome induced by tiopronin: association with the HLA-DR3 antigen. Arthritis Rheum 1985 0.75
142 [The preparation and characterization of steroid antisera (author's transl)]. Ateneo Parmense Acta Biomed 1977 0.75
143 [Gold-induced severe aplastic anemia: medullary autologous reconstitution after immunosuppressive treatment. An observation]. Haematologica 1985 0.75
144 [Recommendations for starting anti TNF-alpha in patients with ankylosing spondylitis]. Reumatismo 2004 0.75
145 Chronic neutrophilic leukemia (CNL) with karyotypic abnormalities associated with plasma cell dyscrasia: a case report. Haematologica 1992 0.75
146 Neurologic involvement as first sign of Behcet's syndrome. Clin Exp Rheumatol 1985 0.75
147 On the utility of CD8 level assessment in the diagnosis of polymyalgia rheumatica/giant cell arteritis. Clin Exp Rheumatol 1995 0.75
148 Focal myositis of the calf muscles. Clin Exp Rheumatol 2008 0.75
149 Tuberculous spondylitis as a cause of inflammatory spinal pain: a report of 4 cases. Clin Exp Rheumatol 1998 0.75
150 HLA typing, platelet associated immunoglobulins and anticardiolipin antibody. J Rheumatol 1986 0.75
151 Endocrine abortion in assisted reproduction technologies (ART). Acta Biomed Ateneo Parmense 1992 0.75
152 [Kaposi's sarcoma during corticoid therapy. Description of a clinical case]. G Clin Med 1982 0.75
153 Anticardiolipin antibodies in a case of neuro-Behçet with superior vena caval occlusion. Clin Rheumatol 1987 0.75